Pharmaceutical Executive

Learn how pharma companies are using robotics and artificial intelligence when it comes to patient care, what the funding landscape is for businesses in this sector, and as a member of the c-suite find out what you need to do now to be at the forefront of this emerging technology.

Learn how pharma companies are using robotics and artificial intelligence when it comes to patient care, what the funding landscape is for businesses in this sector, and as a member of the c-suite find out what you need to do now to be at the forefront of this emerging technology.

Nancy Thornberry, CEO of Kallyope, talks with Michelle Maskaly and Christen Harm about New York City as an emerging hotspot for biotech incubators, and the challenges and opportunities related to space, location, recruitment, and funding.

Jeffrey Nau is CEO of Oyster Point Pharma, a clinical stage pharmaceutical company focused on developing commercial therapies dealing with parasympathetic pathways. In a climate where oncology and rare diseases get most of the attention, Nau talks about what it’s like working on diseases that don’t get the same press, like dry eye, which is the focus of their current Phase 2 clinical trial. How this impacts raising capital and other bumps in the road he has come across. Having extensive experience with raising startup money, Nau outlines some best practices when it comes to funding.

Jeffrey Nau is CEO of Oyster Point Pharma, a clinical stage pharmaceutical company focused on developing commercial therapies dealing with parasympathetic pathways. In a climate where oncology and rare diseases get most of the attention, Nau talks about what it’s like working on diseases that don’t get the same press, like dry eye, which is the focus of their current Phase 2 clinical trial. How this impacts raising capital and other bumps in the road he has come across. Having extensive experience with raising startup money, Nau outlines some best practices when it comes to funding.

Gil Van Bokkelen, CEO and co-founder of Athersys, talks about a pivotal moment during medical school that led him and his co-founders to eventually launch Athersys, the decision to start the company in Ohio instead of his native Northern California, and the secret to staying resilient in the c-suite even when facing extraordinary challenges.

Former NFL star and current sports broadcaster, Solomon Wilcots talks about the intersection of sports and biopharma. He discusses traumatic brain injuries and whether or not the NFL is doing enough about it, projects he has been working on that match professional athletes who are passionate about a certain disease with biopharma companies, and how lessons from the football field can be applied to the boardroom.

Former NFL star and current sports broadcaster, Solomon Wilcots talks about the intersection of sports and biopharma. He discusses traumatic brain injuries and whether or not the NFL is doing enough about it, projects he has been working on that match professional athletes who are passionate about a certain disease with biopharma companies, and how lessons from the football field can be applied to the boardroom.

Michelle Maskaly and Christen Harm host one of Pharm Exec's Emerging Pharma Leaders, Sabina Ewing, vice president of business technology for Pfizer, and discuss the difference and importance of mentoring and sponsoring in business and pharma.
Leadership Tip from Sabina Ewing.

Michelle Maskaly and Christen Harm host the entire Pharmaceutical Executive editorial team on this episode, as we each talk about our Brands of the Year selections and why we chose them.
Leadership Tip from Molly Herbert.